← Leaderboards
Anna R. Smith
Boston University Medical Campus
$75,477
Attributed
$75,477
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $47.7K · FY2023–24$50K$37.5K$25K$12.5K$0
'23
'24
Funding mix
By agency
NIH$75,477 · 1
By mechanism
F31$75,477 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Andrew A Wilson$8,485,651
- Darrell N. Kotton$37,875,782
- David J Waxman$23,862,644
- Kristine Abo$160,107
- N/a N/a$2,600,000
Others in their field
Other Rising Stars on “Alpha 1-Antitrypsin Deficiency”
- Lisa Henn · University Of Michigan At Ann Arbor$1,375,000
- Pamela Valentino · Seattle Children'S Hospital$599,514
- Kenneth N. Olivier · Univ Of North Carolina Chapel Hill$567,109
- Lynn Fussner · Ohio State University$381,240
- Luiz Miguel Quinn Camargo · Ubiquitx, Inc.$313,372
- Rohan Palanki · University Of Pennsylvania$178,372
Research focus
Alpha 1-Antitrypsin DeficiencyAlternative TreatmentAutologousAwardBloodBmp4Cebpa GeneCell Culture TechniquesCell CycleCell DeathCell LineCell MaturationCellsCell SurvivalCell TherapyCell TransplantationCellular EngineeringCirrhosisCovid-19 VaccineCulture MediaDirected DifferentiationDisease ModelDoxycyclineAlpha 1-Antitrypsin
Grant awards (2)
Primary hepatocyte and engineered iPSC-derived hepatocyte-like cell transplantation to treat alpha-1 antitrypsin deficiencyassociated liver disease$27,783
F31 · FY2024 · DK · contact PI
Primary hepatocyte and engineered iPSC-derived hepatocyte-like cell transplantation to treat alpha-1 antitrypsin deficiencyassociated liver disease$47,694
F31 · FY2023 · DK · contact PI